Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized open-label comparison of nystatin gel and suspension versus Mycostatin for oropharyngeal candidiasis
2013-003784-56Phase 3Completed
- Sponsor
- VUAB Pharma
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of nystatin in oral candidiasis (3 arms), sponsored by VUAB Pharma. Primary endpoint: Primary efficacy endpoint. Started Feb 2014; status: completed.
02
Drugs
nystatin
03
Conditions
oral candidiasis
Beyond the preview
Go deeper on 2013-003784-56.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003784-56.